Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.
Kleinman
I
I
Department of Psychiatry, University of Toronto, Ontario, Canada.
Schachter
D
D
Jeffries
J
J
Goldhamer
P
P
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D011939:Mental Recall; D010353:Patient Education as Topic / Q000379:methods*; D010358:Patient Participation; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents